The Inflation Reduction Act, passed by the Biden administration in August 2022, has faced severe criticism from the conservative think tank Advancing American Freedom, founded by former Vice President Mike Pence. Tim Chapman, the organization's president, claims the act has been 'devastating' for Americans, particularly affecting drug prices and benefiting CCP-aligned companies, thereby failing to fulfill its intended purpose. Critics argue that the act has tripled in cost and should be repealed to relieve the American public from its burdens. Additionally, the 340B drug discount program, already criticized for its inefficiencies, has been expanded under the Inflation Reduction Act without addressing its existing flaws, potentially worsening healthcare costs and access issues. The bipartisan implications of these criticisms highlight a growing divide over the effectiveness of the legislation aimed at curbing inflation and aiding healthcare. Overall, the act is positioned by its detractors as a progressive agenda that has not delivered on its promises.